REVOLUTION (Routine EValuatiOn of people LivIng with caNcer)—protocol for a prospective characterisation study of patients with incurable cancer

Patton, R., Cook, J., Haraldsdottir, E., Brown, D., Dolan, R. D. , McMillan, D. C. , Skipworth, R. J. E., Fallon, M. and Laird, B. J.A. (2021) REVOLUTION (Routine EValuatiOn of people LivIng with caNcer)—protocol for a prospective characterisation study of patients with incurable cancer. PLoS ONE, 16(12), e0261175. (doi: 10.1371/journal.pone.0261175)

Abstract

Introduction: There is a pressing need for a holistic characterisation of people with incurable cancer. In this group, where quality of life and improvement of symptoms are therapeutic priorities, the physical and biochemical manifestations of cancer are often studied separately, giving an incomplete picture. In order to improve care, spur therapeutic innovation, provide meaningful endpoints for trials and set priorities for future research, work must be done to explore how the tumour influences the clinical phenotype. Characterisation of the host-tumour interaction may also provide information regarding prognosis, allowing appropriate planning of investigations, treatment and referral to palliative medicine services. Methods: Routine EValuatiOn of people LivIng with caNcer (REVOLUTION) is a prospective observational study that aims to characterise people with incurable cancer around five key areas, namely body composition, physical activity, systemic inflammatory response, symptoms, and quality of life by developing a bio-repository. Participants will initially be recruited from a single centre in the UK and will have assessments of body composition (bio-impedance analysis [BIA] and computed tomography [CT]), assessment of physical activity using a physical activity monitor, measurement of simple markers of inflammation and plasma cytokine proteins and three symptom and quality of life questionnaires. Discussion: This study aims to create a comprehensive biochemical and clinical characterisation of people with incurable cancer. Data in this study can be used to give a better understanding of the ‘symptom phenotype’ and quality of life determinants, development of a profile of the systemic inflammatory response and a detailed characterisation of body composition.

• Item Type: Articles
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Dolan, Dr Ross and Laird, Dr Barry and McMillan, Professor Donald

Creator Roles

Dolan, R. D.: Conceptualization, Methodology
McMillan, D. C.: Conceptualization, Methodology
Laird, B. J.A.: Conceptualization, Supervision, Writing – original draft, Writing – review and editing

• Authors: Patton, R., Cook, J., Haraldsdottir, E., Brown, D., Dolan, R. D., McMillan, D. C., Skipworth, R. J. E., Fallon, M., and Laird, B. J.A.
• College/School: College of Medical Veterinary and Life Sciences > School of Infection & Immunity; College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
• Journal Name: PLoS ONE
• Publisher: Public Library of Science
• ISSN: 1932-6203
• ISSN (Online): 1932-6203
• Copyright Holders: Copyright © 2021 Patton et al.
• First Published: First published in PLoS ONE 16(12): e0261175
• Publisher Policy: Reproduced under a Creative Commons License